Ingenza announces partnership with Cellugy to investigate the potential of biofabricated cellulose

Industrial biotech specialist Ingenza is delighted to announce that it is collaborating with Cellugy to accelerate the development of its innovative platform for producing biofabricated cellulose.

DoxyPEP reduces chlamydia and syphilis rates in routine care

A new study has found that rates of chlamydia and syphilis plummet among people prescribed doxycycline for sexually transmitted infection prevention in routine clinical care.

January 6, 2025

Outbreak of piercing infections in Australia traced to contaminated aftercare solution

Researchers in New South Wales, Australia, used genomic sequencing to trace an outbreak of Pseudomonas aeruginosa infections following ear piercings to a specific batch of

September 4, 2023

Psychedelic Therapy Advancements in Alberta

The TDR Three Key Takeaways regarding Psychedelic Therapy Advancements and Alberta: Psychedelic therapy gains legal and insurance acceptance in Alberta. Psilocybin and MDMA treatments expand

April 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.